君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02511 君圣泰医药-B

已收盘 05-12 16:08:12

3.110

+0.430

+16.04%

最高3.240	最低2.480	成交量1,031万
今开2.690	昨收2.680	日振幅28.36%
总市值16.01亿	流通市值16.01亿	总股本5.15亿
成交额3,082万	换手率2.00%	流通股本5.15亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02511","market":"HK","secType":"STK","nameCN":"君圣泰医药-B","latestPrice":3.11,"timestamp":1747037292029,"preClose":2.68,"halted":0,"volume":10310500,"delay":0,"floatShares":514770668,"shares":514770668,"eps":-0.912703290531696,"marketStatus":"已收盘","change":0.43,"latestTime":"05-12 16:08:12","open":2.69,"high":3.24,"low":2.48,"amount":30816510,"amplitude":0.283582,"askPrice":3.14,"askSize":500,"bidPrice":3.11,"bidSize":9000,"shortable":0,"etf":0,"ttmEps":-0.912703290531696,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747099800000},"marketStatusCode":5,"adr":0,"listingDate":1703174400000,"exchange":"SEHK","adjPreClose":2.68,"openAndCloseTimeList":[[1747013400000,1747022400000],[1747026000000,1747036800000]],"volumeRatio":1.801842,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02511","defaultTab":"news","newsList":[{"id":"1168065393","title":"港股异动 | 君圣泰医药-B午后涨近20%，三项创新研究成果亮相2025欧肝会","url":"https://stock-news.laohu8.com/highlight/detail?id=1168065393","media":"老虎资讯综合","labels":[],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168065393?lang=zh_cn&edition=full","pubTime":"2025-05-12 13:21","pubTimestamp":1747027287,"startTime":"0","endTime":"0","summary":"本周一港股午后， $君圣泰医药-B$ 涨幅直线扩大，一度涨近20%，截至发稿报3.14港元，涨幅17.16%：消息面上，君圣泰医药于欧洲肝脏研究协会2025年大会上发表三项研究成果，分别为熊去氧胆小檗碱针对代谢相关脂肪性肝炎治疗的临床2期研究事后分析结果、针对2型糖尿病治疗的临床2期研究事后分析结果，以及Rimtoregtide在肝衰竭小鼠中的临床前研究结果。这两项3期临床试验结果充分证明了HTD1801一药多效、为T2DM患者提供综合获益的特性。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"重磅！君圣泰医药三大研究成果亮相国际会议，股价应声大涨近20%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"gpt_icon":1},{"id":"2534250619","title":"君圣泰医药-B盘中异动 快速下挫7.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534250619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534250619?lang=zh_cn&edition=full","pubTime":"2025-05-12 09:31","pubTimestamp":1747013476,"startTime":"0","endTime":"0","summary":"2025年05月12日早盘09时31分，君圣泰医药-B股票出现异动，股价大幅下跌7.46%。君圣泰医药-B股票所在的药品行业中，整体跌幅为0.46%。其相关个股中，四环医药、丽珠医药、雅各臣科研制药涨幅较大，振幅较大的相关个股有君圣泰医药-B、翰森制药、凯莱英，振幅分别为8.21%、5.06%、4.92%。因此，在此次交流会上，投资者十分关注君圣泰医药的现金流状况以及未来融资计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512093117a47aa97a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512093117a47aa97a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2534717375","title":"近4年累计亏损17亿元，君圣泰医药进入重要闯关期 董事长刘利平：计划年底递交新药上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2534717375","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534717375?lang=zh_cn&edition=full","pubTime":"2025-05-09 16:28","pubTimestamp":1746779328,"startTime":"0","endTime":"0","summary":"针对代谢相关脂肪性肝炎的2b期研究数据即将揭晓；针对2型糖尿病将完成包括与达格列净头对头研究的3项3期试验数据读出，并计划于年底递交新药上市申请。2024年君圣泰医药录得亏损为3.82亿元，上年同期为9.39亿元，亏损收窄主要因可转债公允价值变动损失减少。据悉，2021年至2022年，君圣泰医药亏损额分别为2.17亿元、2.24亿元，公司近4年累计亏损超17亿元。因此，在此次交流会上，投资者十分关注君圣泰医药的现金流状况以及未来融资计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509163001a477dd60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509163001a477dd60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2534105073","title":"君圣泰医药-B05月09日主力净流入151.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2534105073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534105073?lang=zh_cn&edition=full","pubTime":"2025-05-09 16:15","pubTimestamp":1746778545,"startTime":"0","endTime":"0","summary":"05月09日, 君圣泰医药-B股价涨15.02%，报收2.68元，成交金额1260.0万元，换手率0.96%，振幅16.74%，量比1.02。君圣泰医药-B今日主力资金净流入151.3万元，上一交易日主力净流出112.8万元。该股近5个交易日上涨56.47%，主力资金累计净流入765.4万元；近20日主力资金累计净流入763.5万元，其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509180105a477fc68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509180105a477fc68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2534967129","title":"港股异动 | 君圣泰医药-B(02511)再涨超13% HTD1801临床试验结果达预期 计划年内递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2534967129","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534967129?lang=zh_cn&edition=full","pubTime":"2025-05-09 15:21","pubTimestamp":1746775269,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，君圣泰医药-B再涨超13%，截至发稿，涨11.16%，报2.59港元，成交额964.1万港元。消息面上，君圣泰医药此前宣布，HTD1801在中国T2DM患者中开展的两项3期临床试验中达到了主要终点。SYMPHONY 1和SYMPHONY 2试验显示，HTD1801在HbA1c水平、空腹血糖和血脂指标方面有显著改善，君圣泰医药计划于今年内向国家药品监督管理局药品审评中心递交HTD1801治疗T2DM适应症的新药上市申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291276.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","03347","BK1141","BK1583","02511","BK1161"],"gpt_icon":0},{"id":"2533099879","title":"君圣泰医药-B05月08日主力净流出112.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2533099879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533099879?lang=zh_cn&edition=full","pubTime":"2025-05-08 16:15","pubTimestamp":1746692148,"startTime":"0","endTime":"0","summary":"05月08日, 君圣泰医药-B股价跌10.38%，报收2.33元，成交金额935.5万元，换手率0.77%，振幅21.54%，量比0.97。君圣泰医药-B今日主力资金净流出112.8万元，上一交易日主力净流入103.1万元。该股近5个交易日上涨40.36%，主力资金累计净流入614.1万元；近20日主力资金累计净流入586.1万元，其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508174113a4767f4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508174113a4767f4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2533916495","title":"君圣泰医药-B盘中异动 早盘股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533916495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533916495?lang=zh_cn&edition=full","pubTime":"2025-05-08 09:41","pubTimestamp":1746668506,"startTime":"0","endTime":"0","summary":"2025年05月08日早盘09时41分，君圣泰医药-B股票出现波动，股价大幅跳水5.38%。截至发稿，该股报2.460港元/股，成交量38.55万股，换手率0.07%，振幅13.08%。君圣泰医药-B股票所在的药品行业中，整体跌幅为0.02%。其相关个股中，石药集团、金嗓子、凯莱英涨幅较大，振幅较大的相关个股有君圣泰医药-B、石药集团、信达生物，振幅分别为11.92%、3.66%、2.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508094146a4760670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508094146a4760670&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2533061466","title":"君圣泰医药-B05月07日获主力加仓103.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533061466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533061466?lang=zh_cn&edition=full","pubTime":"2025-05-07 16:15","pubTimestamp":1746605747,"startTime":"0","endTime":"0","summary":"05月07日, 君圣泰医药-B股价涨9.70%，报收2.60元，成交金额1901.7万元，换手率1.47%，振幅23.63%，量比2.76。君圣泰医药-B今日主力资金净流入103.1万元，上一交易日主力净流入623.8万元。该股近5个交易日上涨52.94%，主力资金累计净流入726.9万元；近20日主力资金累计净流入667.7万元，其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507171645a47523ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507171645a47523ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2533611612","title":"君圣泰医药-B盘中异动 早盘股价大涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533611612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533611612?lang=zh_cn&edition=full","pubTime":"2025-05-07 09:31","pubTimestamp":1746581469,"startTime":"0","endTime":"0","summary":"2025年05月07日早盘09时31分，君圣泰医药-B股票出现波动，股价急速上涨5.49%。君圣泰医药-B股票所在的药品行业中，整体跌幅为0.03%。其相关个股中，远大医药、华控康泰、君圣泰医药-B涨幅较大，振幅较大的相关个股有君圣泰医药-B、信达生物、远大医药，振幅分别为8.44%、3.31%、2.84%。君圣泰医药-B公司简介：君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050709311094ee9a6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050709311094ee9a6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2533514301","title":"君圣泰医药-B盘中异动 股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533514301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533514301?lang=zh_cn&edition=full","pubTime":"2025-05-06 09:51","pubTimestamp":1746496268,"startTime":"0","endTime":"0","summary":"2025年05月06日早盘09时51分，君圣泰医药-B股票出现异动，股价大幅上涨5.56%。君圣泰医药-B股票所在的药品行业中，整体跌幅为0.01%。其相关个股中，君圣泰医药-B、中智药业、远大医药涨幅较大，振幅较大的相关个股有君圣泰医药-B、凯莱英、四环医药，振幅分别为9.44%、5.67%、5.41%。君圣泰医药-B公司简介：君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050609510894ed6283&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050609510894ed6283&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2532489462","title":"君圣泰医药-B盘中异动 下午盘股价大涨6.47%报1.810港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532489462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532489462?lang=zh_cn&edition=full","pubTime":"2025-05-02 14:10","pubTimestamp":1746166234,"startTime":"0","endTime":"0","summary":"2025年05月02日下午盘14时10分，君圣泰医药-B股票出现波动，股价大幅上涨6.47%。截至发稿，该股报1.810港元/股，成交量21.1万股，换手率0.04%，振幅7.65%。资金方面，该股资金流入33.106万港元，流出3.6505万港元。君圣泰医药-B股票所在的药品行业中，整体涨幅为0.45%。其相关个股中，三生制药、开拓药业-B、华控康泰涨幅较大，振幅较大的相关个股有华控康泰、三生制药、励晶太平洋，振幅分别为35.71%、13.38%、12.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502141034a6d0cb2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502141034a6d0cb2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":1},{"id":"2531216757","title":"君圣泰医药-B盘中异动 急速下跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531216757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531216757?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:48","pubTimestamp":1745891287,"startTime":"0","endTime":"0","summary":"2025年04月29日早盘09时48分，君圣泰医药-B股票出现波动，股价快速跳水5.29%。君圣泰医药-B股票所在的药品行业中，整体跌幅为0.02%。其相关个股中，三生制药、泰凌医药、励晶太平洋涨幅较大，振幅较大的相关个股有泰凌医药、三生制药、亿胜生物科技，振幅分别为34.48%、8.66%、5.23%。君圣泰医药-B公司简介：君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909480794e6b2c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909480794e6b2c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2530413088","title":"君圣泰医药-B盘中异动 早盘股价大跌5.88%报1.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530413088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530413088?lang=zh_cn&edition=full","pubTime":"2025-04-28 10:48","pubTimestamp":1745808521,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘10时48分，君圣泰医药-B股票出现波动，股价快速下挫5.88%。截至发稿，该股报1.600港元/股，成交量47.35万股，换手率0.09%，振幅6.47%。资金方面，该股资金流入9.144万港元，流出52.176万港元。君圣泰医药-B股票所在的药品行业中，整体跌幅为0.05%。其相关个股中，泰凌医药、长江生命科技、东阳光长江药业涨幅较大，振幅较大的相关个股有泰凌医药、海王英特龙、东阳光长江药业，振幅分别为28.75%、11.43%、10.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042810484194e547a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042810484194e547a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2530929808","title":"君圣泰医药-B盘中异动 股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530929808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530929808?lang=zh_cn&edition=full","pubTime":"2025-04-25 13:26","pubTimestamp":1745558774,"startTime":"0","endTime":"0","summary":"2025年04月25日下午盘13时26分，君圣泰医药-B股票出现波动，股价急速下跌5.46%。截至发稿，该股报1.730港元/股，成交量26.55万股，换手率0.05%，振幅5.46%。君圣泰医药-B股票所在的药品行业中，整体跌幅为0.13%。君圣泰医药-B公司简介：君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425132614aa2c7b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425132614aa2c7b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2529798226","title":"君圣泰医药-B04月24日主力净流入24万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529798226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529798226?lang=zh_cn&edition=full","pubTime":"2025-04-24 16:16","pubTimestamp":1745482575,"startTime":"0","endTime":"0","summary":"04月24日, 君圣泰医药-B股价涨9.58%，报收1.83元，成交金额294万元，换手率0.32%，振幅10.18%，量比2.04。君圣泰医药-B今日主力资金净流入24万元，上一交易日主力净流出0万元。该股近5个交易日上涨15.09%，主力资金累计净流入24万元；近20日主力资金累计净流出50万元，其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170043a465181e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170043a465181e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2529613770","title":"君圣泰医药-B盘中异动 早盘股价大涨5.39%报1.760港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529613770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529613770?lang=zh_cn&edition=full","pubTime":"2025-04-24 10:06","pubTimestamp":1745460387,"startTime":"0","endTime":"0","summary":"2025年04月24日早盘10时06分，君圣泰医药-B股票出现异动，股价快速拉升5.39%。截至发稿，该股报1.760港元/股，成交量37.25万股，换手率0.07%，振幅5.39%。资金方面，该股资金流入50.093万港元，流出12.6555万港元。君圣泰医药-B股票所在的药品行业中，整体涨幅为0.94%。其相关个股中，凯莱英、信达生物、康龙化成涨幅较大，振幅较大的相关个股有凯莱英、泰凌医药、康龙化成，振幅分别为13.63%、8.33%、6.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042410062794e052f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042410062794e052f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2527282904","title":"君圣泰医药-B盘中异动 临近午盘股价大跌5.03%报1.510港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527282904","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527282904?lang=zh_cn&edition=full","pubTime":"2025-04-16 11:30","pubTimestamp":1744774226,"startTime":"0","endTime":"0","summary":"2025年04月16日临近午盘11时30分，君圣泰医药-B股票出现异动，股价快速跳水5.03%。君圣泰医药-B股票所在的药品行业中，整体跌幅为0.60%。君圣泰医药董秘高丽萍介绍，基于此次发布的积极的临床试验数据，君圣泰医药计划于今年内向国家药品监督管理局药品审评中心递交HTD1801治疗2型糖尿病适应症的新药上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041611302794d6e407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041611302794d6e407&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2527590105","title":"港股异动 | 君圣泰医药-B(02511)涨超14% HTD1801在2型糖尿病患者中开展的两项3期临床试验达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2527590105","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527590105?lang=zh_cn&edition=full","pubTime":"2025-04-15 10:01","pubTimestamp":1744682467,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，君圣泰医药-B涨超14%，截至发稿，涨14%，报1.71港元，成交额101.3万港元。消息面上，4月15日，君圣泰医药-B发布公告，公司自主研发的肠肝抗炎及代谢调节剂熊去氧胆小檗硷在中国2型糖尿病患者中开展的两项3期临床试验达成主要疗效终点及多个次要疗效终点。基于此次发布的积极的临床试验数据，君圣泰医药计划于今年内向国家药品监督管理局药品审评中心递交HTD1801治疗T2DM适应症的新药上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","02511","BK1161","BK1583","03347"],"gpt_icon":0},{"id":"2527101814","title":"君圣泰医药-B盘中异动 早盘急速上涨13.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527101814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527101814?lang=zh_cn&edition=full","pubTime":"2025-04-15 09:38","pubTimestamp":1744681126,"startTime":"0","endTime":"0","summary":"2025年04月15日早盘09时38分，君圣泰医药-B股票出现异动，股价大幅拉升13.33%。君圣泰医药-B股票所在的药品行业中，整体涨幅为0.05%。其相关个股中，君圣泰医药-B、中国医疗集团、信达生物涨幅较大，振幅较大的相关个股有君圣泰医药-B、信达生物、四环医药，振幅分别为8.67%、3.51%、3.17%。君圣泰医药-B公司简介：君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041509384694d58901&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041509384694d58901&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2527617820","title":"君圣泰医药-B：熊去氧胆小檗硷(HTD1801)在2型糖尿病患者中开展的两项3期临床试验达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2527617820","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527617820?lang=zh_cn&edition=full","pubTime":"2025-04-15 08:07","pubTimestamp":1744675655,"startTime":"0","endTime":"0","summary":"格隆汇4月15日丨君圣泰医药-B发布公告，公司自主研发的肠肝抗炎及代谢调节剂熊去氧胆小檗硷在中国2型糖尿病患者中开展的两项3期临床试验达成主要疗效终点及多个次要疗效终点。这两项3期临床试验结果充分证明了HTD1801一药多效、为T2DM患者提供综合获益的特性。基于此次发布的积极的临床试验数据，君圣泰医药计划于今年内向国家药品监督管理局药品审评中心递交HTD1801治疗T2DM适应症的新药上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415080735a4590bf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415080735a4590bf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1583","03347","02511","BK1141","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hightidetx.com","stockEarnings":[{"period":"1week","weight":0.4889},{"period":"1month","weight":0.9852},{"period":"3month","weight":1.2333},{"period":"6month","weight":1.1789},{"period":"1year","weight":-0.6171},{"period":"ytd","weight":1.1102}],"compareEarnings":[{"period":"1week","weight":0.0161},{"period":"1month","weight":0.1285},{"period":"3month","weight":0.0821},{"period":"6month","weight":0.1032},{"period":"1year","weight":0.2336},{"period":"ytd","weight":0.14}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"HighTide Therapeutics Inc是一家主要从事原研药生产的公司。该公司专注于代谢疾病、消化系统疾病等领域。该公司开发针对非酒精性脂肪性肝炎（NASH）、2型糖尿病（T2DM）、严重高甘油三酯血症（SHTG）、原发性硬化性胆管炎（PSC）和原发性胆汁性胆管炎（PBC）等适应症的治疗方法。","exchange":"SEHK","name":"君圣泰医药-B","nameEN":"HIGHTIDE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君圣泰医药-B(02511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君圣泰医药-B,02511,君圣泰医药-B股票,君圣泰医药-B股票老虎,君圣泰医药-B股票老虎国际,君圣泰医药-B行情,君圣泰医药-B股票行情,君圣泰医药-B股价,君圣泰医药-B股市,君圣泰医药-B股票价格,君圣泰医药-B股票交易,君圣泰医药-B股票购买,君圣泰医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君圣泰医药-B(02511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}